Affect of fast recovery treatment of gastrointestinal function on clinical outcomes and cost-effectiveness of major in patients with abdominal surgeries: a single-blind randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004395

Enrollment

Unknown

Registered

2014-03-15

Start date

2014-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal surgeries surgeries

Interventions

Experimental:fast recovery treatment of gastrointestinal function

control:current standard treatment

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 70 years, the preoperative pathological diagnosis elective gastrointestinal cancer patients with radical surgery (including gastric cancer, cholangiocarcinoma, pancreatic, duodenal cancer and colonrectal cancer).

Exclusion criteria

Exclusion criteria: 1. Severe heart and lung disease; 2. Diabetes; 3. Serious infections; 4. Dyslipidemia (total triglycerides>2.26mmol/L or total cholesterol>6.2mmol/L); 5. Renal impairment (creatinine >122 umol/L or urea>10.7mmol/L); 6. Splenectomy; 7. Currently receiving hormone therapy.

Design outcomes

Primary

Measure	Time frame
infectious complications;Systemic inflammatory response syndrome;The cost of treating infectious complications;cost/effectivenes;	—

Secondary

Measure	Time frame
non-infectious complications;length of hospital stay;	—

Countries

China

Contacts

Public ContactXu Pengyuan

pyxu778@sina.com.cn+86 13013331809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026